Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Race, class, and place modify mortality rates for the top 12 causes of death, 1999-2021

Allison Formanack, Ayush Doshi, Rupa Valdez, Ishan Williams, View ORCID ProfileJ Randall Moorman, View ORCID ProfilePavel Chernyavskiy
doi: https://doi.org/10.1101/2022.06.14.22276404
Allison Formanack
1University of Southern Mississippi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayush Doshi
2University of Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rupa Valdez
2University of Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ishan Williams
2University of Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Randall Moorman
2University of Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J Randall Moorman
Pavel Chernyavskiy
2University of Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pavel Chernyavskiy
  • For correspondence: pchern{at}virginia.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objectives To disarticulate the associations of race (whiteness), class (socioeconomic status), and place (county) with risk of cause-specific death in the US.

Methods We studied mortality in US counties for 11 causes of death (1999-2019) and COVID-19 (2020-2021). We adjusted for race and age using the American Community Survey and socioeconomic status using the Area Deprivation Index. Bayesian regressions with spatial county effects were estimated for inference.

Results County whiteness and socioeconomic status modified death rates; geospatial effects differed by cause of death. Other factors equal, a 20% increase in county whiteness was associated with 5-8% increase in death from three causes and 4-15% reduction in death from others, including COVID-19. Other factors equal, advantaged counties had significantly lower death rates, even when juxtaposed with disadvantaged ones. Geospatial patterns of residual risk varied by cause of death. For example, cancer and heart disease death rates were better explained by age, socioeconomic status, and county whiteness than were COVID-19 and suicide deaths.

Conclusions There are important independent contributions from race, class, and geography to risk of death in the US.

INTRODUCTION

Motivation

Disparity and inequity in healthcare are legion in the United States (US). The National Institutes of Health defines levels of analysis in health disparities to be environmental, sociocultural, behavioral, and/or biological. Among these categories, public health literature is typically focused on geographical and socio-economic factors, racial and ethnic factors, health behaviors, as well as physiological factors, such as the prevalence and type of disabilities. Further, formally-recognized priority populations for disparities research include, but are not limited to: racial, ethnic, sexual orientation and gender minorities, socio-economically disadvantaged populations, rural populations, and disabled populations1. Unfortunately, validated public data with an appropriate level of geographic detail that contain measurement on these factors and sub-populations are limited. However, racial and ethnic composition (race and ethnicity), socio-economic status (class), and geographic location (place) have better established measures and validated data sources, and thus best lend themselves to further study and will be the focus of this article.

These three variables - self-reported race and ethnicity, class, and place - are well-known risk factors for death, alongside, of course, age. Even high-quality recent efforts to investigate US health disparities frequently consider one or two of these at a time, rather than adjusting simultaneously for all three2–5. In cases where all three are considered, researchers tend to focus on one or only on a few causes of death6,7. Thus, less is known about how these three fundamental drivers of health disparities will contribute jointly to mortality, nor is it known how these drivers differ by cause of death.

Not only do we expect all three of race, class, and place to matter, but we also expect interaction among them. For example, due to systemic racism and structural housing discrimination, racial minorities tend to live in more disadvantaged communities across the US8. Intuitively, both joint and independent contributions of the three factors are not expected to be identical for all causes of death. For example, it is not clear that the variables associated with health disparity and geospatial landscape are the same for suicide as they are for influenza. Here, we use a county-level regression framework to investigate how socioeconomic status, county racial make-up, and geography contribute to risk of age-adjusted mortality for the top-12 causes of death in 2020. This approach allows us to analyze the contribution of each factor when adjusted for the others.

Race and ethnicity, class, and place

Race and ethnicity are social and cultural constructs that are not biologically based, but nevertheless impact death rates. Our focus is on the racial make-up of US counties, and our measure is the proportion of residents that identify as non-Hispanic white in the 5-year American Community Survey. We call this metric the “whiteness” of the county, following critical race theorists who distinguish between “white people” as a descriptor and “whiteness” as a sociocultural construct and lived experience of systemic racial privilege and advantage9–11. In the US, white raciality provides structural and systemic advantages that affect health outcomes, even as socio-cultural definitions of whiteness have shifted over time12. As a consequence of racial privilege and structural racism, non-Hispanic whiteness is often regarded as normative in relation to all other racial identities, in particular Black or African American populations13. Our research objective is to determine the association of non-Hispanic whiteness, with mortality rates of the top-12 causes of death, a list that prominently includes COVID-19. By focusing on whiteness defined in this way, our analysis directly measures the effects of privilege associated with whiteness on health outcomes.

Class, by which we here mean socioeconomic status (SES), also affects health outcomes but is harder to measure. We used the 2018 Area Deprivation Index (ADI) percentiles for US block-groups that were aggregated to the level of county14. The ADI is a validated factor-based index composed of 17 census variables that measure areal levels of education, employment, income, poverty, and housing15. By spatializing these factors, the ADI is an effective predictor for mortality15,16 and life expectancy16,17. Worse ADI18 and rising food insecurity19 are associated with cardiovascular mortality, and that high ADI is a risk factor for hospital readmission of the same magnitude as Chronic Obstructive Pulmonary Disease (COPD) and more than diabetes20. This is especially true for sepsis21 and after surgery22–25. Importantly, we note that the formulation of the ADI omits racial and ethnic makeup, but may well encode its effects9–11.

Place, like race/ethnicity and SES, has an impact on health outcomes. The integral role of place (i.e., spatial context) in health disparities is formally recognized by the US Department of Health and Human Services26,27 via its Social Determinants of Health (SDH). As such, counties reflect the essential variability in socio-demographics and the built environment, and thereby serve as effective proxies for the SDH domains of Health Care Access and Quality, Neighborhood and Built Environment, and Social and Community Context. In addition, risk factors for common diseases cluster: for example, hypertension is more common in the southern US, and thus we can expect higher rates of death from heart and kidney disease. Most recently, the pandemic has thrown into especially sharp relief the differences in death rates across the country. Likewise, COVID vaccination uptake varies regionally28, as do local pandemic-related community prevention efforts, leading to strong geospatial patterns of pandemic mortality29.

Our analysis of place-based risk bears elaboration. Here, we consider the patterns of ADI formed by adjacent counties in addition to the risk associated with residence in each county. To do so, we partition US counties into one of several geographic profiles: clusters of advantage and disadvantage, outliers of advantage and disadvantage, and neither clustered nor outlying counties. As such, our analysis formally reflects the (dis)advantage of each county relative to its neighbors, which could reflect factors otherwise not accounted for by analyzing each county individually. For example, we might expect geographical differences in access to healthcare, socio-cultural resources, and so on.

Here, we bring race, class, and place into the same analytic frame to measure their contributions and interactions30 in influencing population health outcomes. Our statistical models also reveal the impact of latent variables - we call them geographic risk modifiers - that capture the joint impact of all factors not explicitly given by our measures of race, class, and place. We expect these factors to be complex and nuanced, and plausible mechanisms must draw on concepts of syndemics and intersectionality.

METHODS

We obtained death certificate-based county level counts and person-years at risk for the top 11 causes of death 1999-2019 from the CDC Wonder database31, and for COVID-19 over 2020-2021 from the Johns Hopkins Center for Systems Science and Engineering32. COVID-19 mortality spanned January 1, 2020 - October 17, 2021. Due to missing ADI, we analyzed data in all but 7 counties, 4 of which were in Hawaii. We show the unadjusted and unsmoothed mortality rates, depicted as cause-specific Z-scores in Supplementary Figure 1. Mapped in this manner, a county with a value of 2 for heart disease, for example, has an unadjusted rate two standard deviations above the US average for heart disease.

ADI Clustering using Local Moran’s I

To concentrate the effects of areal deprivation and reduce confounding with the smooth spatial county effects, we employed Local Moran’s I33 computed using GeoDa open-source software34. This analysis effectively assigns each county to either a deprivation cluster or outlier status based on its Area Deprivation Index (ADI) and the ADI of its immediate neighbors. The resultant disadvantaged clusters were disadvantaged counties surrounded by disadvantage, whereas advantaged clusters were advantaged counties surrounded by advantage. Disadvantaged outliers and advantaged outliers were spatial outliers that are statistically significantly different from their neighbors. We used alpha=0.05 to detect clusters and outliers. Together with the non-cluster-non-outlier grouping - where Local Moran’s I yielded p-values > 0.05 - we created a 5-level categorical variable that jointly reflects the levels of deprivation of each county, as well as that of its first-order neighbors.

Statistical Analysis

We estimated 12 Bayesian regression models - one per cause of death - each with a person-years- at-risk “offset term” (Ei) and explanatory variables of: county age demographics (% aged <18, % aged >65) and % non-Hispanic white residents from the 5-year American Community Survey35, as well as the 5-level ADI cluster type (reference = non-cluster-non-outliers). Each model also included a cause-specific spatial county effect (ui) to account for spatial correlation, which was specified using the recent BYM2 formulation36. We used the negative-binomial likelihood that accounts for overdispersion in the data. The analysis was implemented using standard code within the brms package version 2.15 in R37.

The expected count of cause-specific deaths for the ith county was specified as: Embedded Image where W is the county adjacency matrix. Counties were deemed adjacent using the “queen” rule: if their borders shared at least one vertex. For causes of death where exact mortality counts were censored by the CDC due to being too small, we applied an identically-specified left-censored negative binomial regression38.

Spatial effects {ui, …, uN } reflect patterns of risk attributable to geographic location, after adjustments due to age, race, and class. In other words, they reflect the aggregate contribution of unmeasured or unmeasurable factors unique to each county. In the results, we present estimates on a common Relative Risk (RR) scale for all causes of death, motivating their interpretation as a geographic risk modifier, where RR = 1 reflects no modification beyond what is explained by the other explanatory variables.

All quantitative explanatory variables were centered and scaled prior to analysis. We adjusted the prior distributions and MCMC sampling parameters in each model to balance execution times - typically long in spatial analysis - with convergence metrics. This sampling strategy was adjusted until convergence was deemed acceptable for each cause of death. The details of our sampling parameters, as well as the prior distributions used, are shown in Supplementary Table 2.

As a sensitivity analysis, we used standard 5-year categorical age groups instead of continuous age percentages, as well as the more parsimonious Intrinsic Conditional Autoregressive correlation structure. Using categorical ages resulted in lower uncertainty due to pseudo-replication of ADI cluster effects across age groups, but neither the direction nor the statistical significance of the coefficients were substantially altered. Similarly, using a more parsimonious correlation structure did not qualitatively alter our findings. Thus, we report the results from analyses with the simplified age structure and using the BYM2 spatial model, as shown above.

RESULTS

Race: County whiteness predicted mortality rates

Greater county whiteness was associated with lower risk of death for 9 of 12 leading causes, after adjusting for age, class, and place (Figure 1). Counties with a higher proportion of white residents had at least 4% lower rates of 8 of the top 12 causes of death. The greatest disadvantages occurred in kidney disease, septicemia, diabetes, and COVID-19, where death rates were 12 to 15% lower in counties with a higher proportion of white residents. Deaths due to suicide, chronic lower respiratory disease, and Alzheimer’s disease were higher in whiter counties. The adjusted risk of death due to cancer, on the other hand, was less affected by county whiteness with Relative Risk (RR)=0.99 (95% Credible Interval 0.98, 0.99) per 20% increase in county whiteness.

Figure 1.
  • Download figure
  • Open in new tab
Figure 1.

Race and cause of death. The data points are cause-specific adjusted relative risks (RR) per 20% (1 SD) increase in county whiteness (% of non-Hispanic white residents), sorted according to the RR estimate. Bars are 95% equal-tail Credible Intervals. All RR are adjusted for age, class (Area Deprivation Index clusters), and place (cause-specific geographic risk modifiers); RR = 1 indicates that the risk is independent of race (county whiteness).

Class: Area Deprivation Index clusters predicted mortality rates

We found that 696 (22.2%) counties were in a disadvantaged cluster, 504 counties (16.1%) were in an advantaged cluster, 21 counties (0.7%) were disadvantaged outliers, 28 counties (0.9%) were advantaged outliers, and the remaining counties (60.1%) were neither outliers nor in a cluster. Advantaged-cluster counties were generally situated in states along the Pacific coast, in the Northeast metropolitan corridor and New England, and in portions of the Mountain West states (Colorado, Wyoming, Montana, and Utah). Disadvantaged-cluster counties were concentrated in non-coastal counties in the South, portions of the Midwest, and also in portions of Appalachia. An interactive online map of the computed ADI clusters and outliers can be accessed using this link.

Residence in an advantaged cluster was associated with significantly lower risk for 9 of 12 causes of death. Relative to non-cluster-non-outlier counties, these Relative Risks (RR) ranged from 0.89 (95% CrI: 0.80, 0.99) for COVID-19 to 0.98 (0.96, 1.00) for cancer (Figure 2; bottom panel). Conversely, residence in a disadvantaged cluster was associated with significantly higher risk for 8 of 12 causes of death, with RRs ranging from 1.02 (1.01, 1.04) for cancer to 1.11 (1.07, 1.15) for influenza and pneumonia (Figure 2; top panel).

Figure 2.
  • Download figure
  • Open in new tab
Figure 2.

Class and cause of death. Points are cause-specific adjusted relative risks (RR) for counties belonging to an ADI-based disadvantaged cluster, advantaged outlier, disadvantaged outlier, or advantaged cluster vs. non-cluster-non-outlier. Open circles indicate that RR=1 is included in a 95% equal-tail Credible Interval; RR=1 indicates risk of death is independent of cluster type. All RR are adjusted for age, race and ethnicity (whiteness), and place (cause-specific geographic risk modifiers) and are ranked by the total number of deaths within each panel.

Residence in an outlier county was often associated with more extreme RR compared to residence in a cluster. For example, the RR for chronic lower respiratory disease in a disadvantaged outlier was 19.4% higher than a disadvantaged cluster. On the other hand, the RR for Alzheimer’s disease in an advantaged outlier was 4.7% lower than in an advantaged cluster.

Surprisingly, Alzheimer’s disease mortality was unlike all other causes of death with an RR substantially below 1 in disadvantaged outlier counties and not significantly different elsewhere.

Place: geographic risk modifiers differed markedly by cause of death

Figure 3 shows that geographic risk modifiers for kidney disease, septicemia, and COVID-19 were elevated in the Southeast and Northeast, and for COVID-19 across parts of the South, Midwest, and the Mountain-West states. On the other hand, geographic risk modifiers for accidental deaths and suicides tended to be higher across the West, including Alaska. Modifiers for Alzheimer’s further differed and were localized in several counties within South Dakota, North Dakota, and Washington. Finally, modifiers for chronic lower respiratory disease were localized in Colorado and Kentucky. To our surprise, the top two causes of death - heart disease and cancer - had the least variable effects, with little geographic modification of risk due after accounting for other factors.

Figure 3.
  • Download figure
  • Open in new tab
Figure 3.

Place and cause of death. Maps reflect cause-specific geographic risk modifiers after adjustments for age, race and ethnicity (whiteness), and class (ADI-based clusters). The color scale reports the Relative Risk and can be interpreted as a place-based multiplier of cause-specific mortality.

Geographic risk modifiers for heart disease, cancer, kidney disease, and septicemia were inter-correlated (Spearman ρ > 0.65), and thus co-located in a similar set of counties (Supplementary Figure 2). Similarly, risk modifiers for stroke and heart disease (ρ = 0.61), and accidental injuries and suicide (ρ = 0.56) co-located. Conversely, risk modifiers for suicide were statistically significantly anti-correlated with heart disease (ρ = -0.15), stroke (ρ = -0.18), and COVID-19 (ρ = -0.37), indicating those occur in different sets of counties.

The high correlation between cause-specific geographic risk modifiers and observed mortality rates indicates important non-race, non-class risk factors were present. Spearman correlations ranged from 0.88 (COVID-19) to 0.39 (cancer) (Supplementary Table 1). At the extremes, these correlations indicate cancer mortality patterns were much better explained by age, race, and class than patterns of COVID-19 mortality.

DISCUSSION

For the leading causes of death in 2020, we jointly evaluated the impacts of self-reported race and ethnicity, class, and place at the county level. The major strengths of our study include the use of sophisticated analytical tools, authoritative data sources, and the complete list of the 12 most common causes of death. Moreover, we treated these fundamental risk factors as statistically independent, measuring the influence of one adjusted for the others. Our measures of race/ethnicity, class, and place do not overlap; for example, our measure of class (the ADI) does not include race, ethnicity, or place. Our major finding is that race, class, and place each contribute to mortality risk and these contributions differ markedly by cause of death. Our findings suggest there are at least three mechanisms responsible for structural inequalities present in US healthcare today.

Race and ethnicity, measured here by county whiteness, was protective for 9 causes and not protective for 3 causes of death. Whiteness affords no physiological benefits, but it historically affords social advantages that allow access to healthcare and other mechanisms for improved outcomes. For example, although the protective whiteness effect for heart disease - the number one cause of death - was relatively small among the causes studied, treatments have long been administered to fewer Black patients than white39. The protective whiteness effect for COVID-19 - the third leading cause in 2020 - was particularly pronounced in our data, which mirrors previous findings of greater risk to ethnic and racial minority populations6,7,40. From a statistical perspective, working with county whiteness affords us sufficient numeric range to maximize statistical power to detect disparities when they are present. In fact, county-level data on every possible racial and ethnic subgroup are sparse and estimates may lead to spurious conclusions.

Class, measured by the ADI, was associated with risk of death from all of the top 12 causes of death. As expected, we found that disadvantaged counties had worse outcomes and advantaged counties had better outcomes. To our surprise, we found that juxtaposition of counties with different levels of advantage did not have intermediate effects. That is, disadvantaged outlier counties did not benefit from the proximity of advantaged neighbors, nor did advantaged outlier counties suffer from disadvantaged neighbors. It is plausible that counties are geographically too large for these kinds of intermediate effects to arise; our work should be reproduced on smaller geographic units (e.g., census tracts) to determine if the patterns we observed persist. Additionally, there were relatively few ADI outlier counties (49 across both types of outliers), and we found no consistent features of these counties. We note, however, that 5 of the 28 advantaged outlier counties housed large research universities in the southern US, 4 of them in Mississippi alone. Within these counties, outcomes were much better than for their immediate neighbors. The mechanisms are not known but might include the presence of a stable workforce with healthcare benefits, as well as superior health and community infrastructure, for example: access to specialist physicians, community investment in greenspaces, and access to healthy foods.

Place, after adjusting for race and class, had a strong effect on mortality through geographic risk modifiers that differed substantially by cause of death. We observed patterns consistent with known clusters, such as the “Heart Failure belt” and “Stroke belt” in the Southeast41,42, the “Suicide belt” in the West43, and to a lesser degree, “Cancer alley” in counties along the Mississippi River in the South44,45. Our analysis also indicates clusters of COPD in Colorado and Kentucky, perhaps explained by the history of mining, as evidenced by the presence of federal Black Lung clinics46. Additionally, our results highlight previously unreported regional patterns, such as the clustering of high-risk geographic modifiers for kidney disease and septicemia in the eastern US, notably excluding Tennessee and Florida.

We note especially the effects of race, class, and place on COVID-19 deaths. Race had a profound effect: county whiteness protected against COVID deaths in this analysis, consistent with other reports. The effect was one of the strongest that we found and was matched only by diabetes mortality. Likewise, class had a strong effect: residents of advantaged clusters were most protected from COVID deaths among the twelve causes under study. Additionally, with respect to place, we found complex nation-wide patterns of COVID-19 deaths. For example, several Native American nations in Arizona, New Mexico, Wyoming, and Montana have mortality risk in excess of what can be attributed to race and class, highlighting the local challenges of healthcare delivery in those locales47. In stark contrast, large portions of the US West, and especially California, Oregon, Washington, Utah, and Nevada, were relatively protected from COVID-19 mortality, after adjusting for race and class.

While our analysis statistically isolates each variable from the others, we note the potential intersections of race, class, and place for some of the causes of death. For example, in areas that benefit from sustained economic growth (e.g., “Silicon Valley”), which may form advantaged clusters and outliers, we find favorable mortality for diabetes and chronic lower respiratory disease. Likewise, we find that class and race may intersect for Alzheimer’s disease, which is not only of higher prevalence among African American/Black populations and underdiagnosed as well48. Finally, we find that place and race intersect in the western US, with higher county whiteness as well as rates of suicide49 and other “deaths of despair”50.

Taken together, we regard these intersections of race, class, and place as empirical evidence that supports syndemics theory. As a conceptual framework, syndemics treats health inequities as a confluence of biosocial factors, in particular the structural, historical, and cultural systems that inform individual decision-making51. Syndemics analyses have been done for each cause of death we identify in this paper, including COVID-1952,53; however, there is little evidence that supports syndemics theories in practice54. Here, we present an empirical basis for syndemics that shows where spatially-structured risk accentuates socially-structured risk. Specifically, we are able to demonstrate: (1) how whiteness affects mortality for the top 12 causes of death; (2) how socioeconomic advantage and disadvantage is mediated by racial and geographic proximity; and (3) that morbidities cluster in specific biosocial patterns independent of race and class. We argue that these conclusions cannot be reached without simultaneously attending to the intersection of race, class, and place as syndemic risk modifiers.

This work represents the first known evidence55,56 for syndemics theory that does not rely on behavioral data; however, we acknowledge several limitations. Using aggregated data carries an inherent risk of committing ecological bias. To this end, we emphasize that our smallest unit of analysis is the county and take care to limit our scope of inference no further. Counts of deaths due to COVID have been subject to underreporting57, especially for racial and ethnic minorities. Thus, we are limited by the quality of the data publicly available through the CDC. Because we focus our article on race, class, and place, several potential risk factors were not part of this analysis, perhaps most prominently, biological sex. Indeed, there are known sex differences for several leading causes of deaths, including heart disease58, cancer59, and suicide60. Likewise, we do not consider other factors that contribute to health disparities, such as the prevalence and type of disabilities61,62 in the population, or the prevalence of individuals who identify as something other than cisgender and heterosexual63. However, investigating the interaction of these factors with race, class, and place falls outside the scope of the current work, and presents a fecund direction for future research. Finally, we note that county whiteness is a function of self-reported race, ascertained at the county level through the American Community Survey. And, while we report non-Hispanic white as the reference standard, we note that the reality of racial and ethnic makeup in the US is far more complex than a simple “white/non-white” binary.

PUBLIC HEALTH IMPLICATIONS

We offer two perspectives on public health implications. First, our article supports syndemics theory, in that we offer empirical evidence for race, class, and place as intersectional, rather than independent operators affecting differential outcomes in mortality for the top 12 causes. Second, existing measures of deprivation like the ADI are useful for identifying macro-level trends, but their usefulness is limited for local health departments, which tend to operate at the county level, with a decentralized structure meant to respond to local health conditions. In addition to other findings, our study illustrates how macro-level datasets can be analyzed in a way that is more suited to the needs of local health departments and their partners.

Data Availability

Data available upon reasonable request to authors.

ACKNOWLEDGEMENTS

We thank D.S. Wessel, MD, for help with literature review and K. Krahn for assistance with manuscript preparation.

Footnotes

  • Introduction, Methods, Discussion text revised. Citations added throughout manuscript.

References

  1. 1.↵
    Hill, C. V., Pérez-Stable, E. J., Anderson, N. A. & Bernard, M. A. The National Institute on Aging health disparities research framework. Ethn. Dis. 25, 245–254 (2015).
    OpenUrlCrossRefPubMed
  2. 2.↵
    GBD US Health Disparities Collaborators. Life expectancy by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities. Lancet (2022) doi:10.1016/S0140-6736(22)00876-5.
    OpenUrlCrossRef
  3. 3.
    Davis Lynn, B. C., Chernyavskiy, P., Gierach, G. L. & Rosenberg, P. S. Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region. J Natl Cancer Inst 114, 263–270 (2022).
    OpenUrl
  4. 4.
    Jatoi, I., Sung, H. & Jemal, A. The Emergence of the Racial Disparity in U.S. Breast-Cancer Mortality. N. Engl. J. Med. 386, 2349–2352 (2022).
    OpenUrl
  5. 5.↵
    Ma, J. et al. Progress in reducing disparities in premature mortality in the USA: a descriptive study. J. Gen. Intern. Med. (2022) doi:10.1007/s11606-021-07268-5.
    OpenUrlCrossRef
  6. 6.↵
    Magesh, S. et al. Disparities in COVID-19 Outcomes by Race, Ethnicity, and Socioeconomic Status: A Systematic-Review and Meta-analysis. JAMA Netw. Open 4, e2134147 (2021).
    OpenUrl
  7. 7.↵
    Shiels, M. S. et al. Premature mortality from all causes and drug poisonings in the USA according to socioeconomic status and rurality: an analysis of death certificate data by county from 2000-15. Lancet Public Health 4, e97–e106 (2019).
    OpenUrl
  8. 8.↵
    Riley, A. R. Neighborhood Disadvantage, Residential Segregation, and Beyond-Lessons for Studying Structural Racism and Health. J. Racial Ethn. Health Disparities 5, 357–365 (2018).
    OpenUrl
  9. 9.↵
    Harris, C. I. Whiteness as Property. Harv. Law Rev. 106, 1707 (1993).
    OpenUrlCrossRefWeb of Science
  10. 10.
    Stubblefield, A. Revealing whiteness: the unconscious habits of racial privilege. by shannon sullivan. bloomington: indiana university press, 2006. Hypatia 23, 190–193 (2008).
    OpenUrl
  11. 11.↵
    Twine, F. W. & Gallagher, C. The future of whiteness: a map of the ‘third wave.’ Ethn. Racial Stud. 31, 4–24 (2008).
    OpenUrlCrossRefWeb of Science
  12. 12.↵
    Rambachan, A. Overcoming the racial hierarchy: the history and medical consequences of “caucasian”. J. Racial Ethn. Health Disparities 5, 907–912 (2018).
    OpenUrl
  13. 13.↵
    Castle, B., Wendel, M., Kerr, J., Brooms, D. & Rollins, A. Public health’s approach to systemic racism: a systematic literature review. J. Racial Ethn. Health Disparities 6, 27–36 (2019).
    OpenUrl
  14. 14.↵
    Kind, A. J. H. & Buckingham, W. R. Making neighborhood-disadvantage metrics accessible - the Neighborhood Atlas. N. Engl. J. Med. 378, 2456–2458 (2018).
    OpenUrlCrossRefPubMed
  15. 15.↵
    Singh, G. K. Area deprivation and widening inequalities in US mortality, 1969-1998. Am. J. Public Health 93, 1137–1143 (2003).
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    Singh, G. K. & Siahpush, M. Widening socioeconomic inequalities in US life expectancy, 1980-2000. Int. J. Epidemiol. 35, 969–979 (2006).
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    Singh, G. K. & Siahpush, M. Increasing inequalities in all-cause and cardiovascular mortality among US adults aged 25-64 years by area socioeconomic status, 1969-1998. Int. J. Epidemiol. 31, 600–613 (2002).
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    Khatana, S. A. M. et al. Association Between County-Level Change in Economic Prosperity and Change in Cardiovascular Mortality Among Middle-aged US Adults. JAMA 325, 445–453 (2021).
    OpenUrl
  19. 19.↵
    Wang, S. Y. et al. Food Insecurity and Cardiovascular Mortality for Nonelderly Adults in the United States From 2011 to 2017: A County-Level Longitudinal Analysis. Circ. Cardiovasc. Qual. Outcomes 14, e007473 (2021).
    OpenUrl
  20. 20.↵
    Kind, A. J. H. et al. Neighborhood socioeconomic disadvantage and 30-day rehospitalization: A retrospective cohort study. Ann. Intern. Med. 161, 765–774 (2014).
    OpenUrlCrossRefPubMed
  21. 21.↵
    Galiatsatos, P. et al. The association between neighborhood socioeconomic disadvantage and readmissions for patients hospitalized with sepsis. Crit. Care Med. 48, 808–814 (2020).
    OpenUrlPubMed
  22. 22.↵
    Ghirimoldi, F. M. et al. Association of Socioeconomic Area Deprivation Index with Hospital Readmissions After Colon and Rectal Surgery. J. Gastrointest. Surg. (2020) doi:10.1007/s11605-020-04754-9.
    OpenUrlCrossRef
  23. 23.
    Mehaffey, J. H. et al. Community level socioeconomic status association with surgical outcomes and resource utilisation in a regional cohort: a prospective registry analysis. BMJ Qual. Saf. 29, 232–237 (2020).
    OpenUrlAbstract/FREE Full Text
  24. 24.
    Mehaffey, J. H. et al. Socioeconomically Distressed Communities Associated With Long-term Mortality After Bariatric Surgery. J. Surg. Res. 243, 8–13 (2019).
    OpenUrl
  25. 25.↵
    Mehaffey, J. H. et al. Socioeconomic “Distressed Communities Index” Improves Surgical Risk-adjustment. Ann. Surg. 271, 470–474 (2020).
    OpenUrl
  26. 26.↵
    Healthy People 2020 |. https://www.healthypeople.gov/2020/.
  27. 27.↵
    Healthy People 2030 | health.gov. https://health.gov/healthypeople.
  28. 28.↵
    Madorsky, T. Z., Adebayo, N. A., Post, S. L., O’Brian, C. A. & Simon, M. A. Vaccine distrust: A predictable response to structural racism and an inadequate public health infrastructure. Am. J. Public Health 111, S185–S188 (2021).
    OpenUrl
  29. 29.↵
    Zalla, L. C., Mulholland, G. E., Filiatreau, L. M. & Edwards, J. K. Racial/Ethnic and Age Differences in the Direct and Indirect Effects of the COVID-19 Pandemic on US Mortality. Am. J. Public Health 112, 154–164 (2022).
    OpenUrl
  30. 30.↵
    Poteat, T. Navigating the storm: how to apply intersectionality to public health in times of crisis. Am. J. Public Health 111, 91–92 (2021).
    OpenUrl
  31. 31.↵
    CDC WONDER. https://wonder.cdc.gov/.
  32. 32.↵
    COVID-19 Map - Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html.
  33. 33.↵
    Anselin, L. Local Indicators of Spatial Association-LISA. Geogr. Anal. 27, 93–115 (1995).
    OpenUrlCrossRefWeb of Science
  34. 34.↵
    1. Fischer, M. M. &
    2. Getis, A
    Anselin, L., Syabri, I. & Kho, Y. Geoda: an introduction to spatial data analysis. in Handbook of applied spatial analysis (eds. Fischer, M. M. & Getis, A.) 73–89 (Springer Berlin Heidelberg, 2010). doi:10.1007/978-3-642-03647-7_5.
    OpenUrlCrossRef
  35. 35.↵
    American Community Survey Information Guide. https://www.census.gov/programs-surveys/acs/library/information-guide.html.
  36. 36.↵
    Riebler, A., Sørbye, S. H., Simpson, D. & Rue, H. An intuitive Bayesian spatial model for disease mapping that accounts for scaling. Stat. Methods Med. Res. 25, 1145–1165 (2016).
    OpenUrlCrossRefPubMed
  37. 37.↵
    Bürkner, P.-C. brms: an R package for bayesian multilevel models using stan. J. Stat. Softw. 80, (2017).
  38. 38.↵
    Chernyavskiy, P., Little, M. P. & Rosenberg, P. S. Spatially varying age-period-cohort analysis with application to US mortality, 2002-2016. Biostatistics 21, 845–859 (2020).
    OpenUrl
  39. 39.↵
    Mazimba, S. & Peterson, P. N. JAHA spotlight on racial and ethnic disparities in cardiovascular disease. J. Am. Heart Assoc. 10, e023650 (2021).
    OpenUrl
  40. 40.↵
    Feldman, J. M. & Bassett, M. T. Variation in COVID-19 Mortality in the US by Race and Ethnicity and Educational Attainment. JAMA Netw. Open 4, e2135967 (2021).
    OpenUrl
  41. 41.↵
    Mujib, M., Zhang, Y., Feller, M. A. & Ahmed, A. Evidence of a “heart failure belt” in the southeastern United States. Am. J. Cardiol. 107, 935–937 (2011).
    OpenUrlCrossRefPubMed
  42. 42.↵
    Howard, G. & Howard, V. J. Twenty years of progress toward understanding the stroke belt. Stroke 51, 742–750 (2020).
    OpenUrlCrossRefPubMed
  43. 43.↵
    Castro, J. Where is the Suicide Belt | Causes of Suicide | Live Science. https://www.livescience.com/34470-suicide-belt.html (2013).
  44. 44.↵
    Terrell, K. A. & James, W. Racial Disparities in Air Pollution Burden and COVID-19 Deaths in Louisiana, USA, in the Context of Long-Term Changes in Fine Particulate Pollution. Environmental Justice (2020) doi:10.1089/env.2020.0021.
    OpenUrlCrossRef
  45. 45.↵
    Singer, M. Down cancer alley: the lived experience of health and environmental suffering in Louisiana’s chemical corridor. Med. Anthropol. Q. 25, 141–163 (2011).
    OpenUrlPubMed
  46. 46.↵
    Rush, J. Black Lung Clinics Program | Official web site of the U.S. Health Resources & Services Administration. https://www.hrsa.gov/get-health-care/conditions/black-lung (2021).
  47. 47.↵
    Gartner, D. R., Wilbur, R. E. & McCoy, M. L. “american indian” as a racial category in public health: implications for communities and practice. Am. J. Public Health 111, 1969–1975 (2021).
    OpenUrl
  48. 48.↵
    Lennon, J. C. et al. Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation. Alzheimers Dement (2021) doi:10.1002/alz.12509.
    OpenUrlCrossRef
  49. 49.↵
    Hayes, S. L., Radley, D. C. & McCarthy, D. States of Despair: A Closer Look at Rising State Death Rates from Drugs, Alcohol, and Suicide. Commonwealth Fund (2018) doi:10.26099/wjrf-xt20.
    OpenUrlCrossRef
  50. 50.↵
    Case, A. & Deaton, A. Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc Natl Acad Sci USA 112, 15078–15083 (2015).
    OpenUrlAbstract/FREE Full Text
  51. 51.↵
    Singer, M., Bulled, N., Ostrach, B. & Mendenhall, E. Syndemics and the biosocial conception of health. Lancet 389, 941–950 (2017).
    OpenUrlCrossRefPubMed
  52. 52.↵
    Ecks, S. Multimorbidity, Polyiatrogenesis, and COVID-19. Med. Anthropol. Q. 34, 488–503 (2020).
    OpenUrl
  53. 53.↵
    Singer, M. & Rylko-Bauer, B. The syndemics and structural violence of the COVID pandemic: anthropological insights on a crisis. Open Anthropological Research 1, 7–32 (2021).
    OpenUrl
  54. 54.↵
    Tsai, A. C. Syndemics: A theory in search of data or data in search of a theory? Soc. Sci. Med. 206, 117–122 (2018).
    OpenUrlCrossRefPubMed
  55. 55.↵
    Stall, R. et al. Association of co-occurring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. Am. J. Public Health 93, 939–942 (2003).
    OpenUrlCrossRefPubMedWeb of Science
  56. 56.↵
    Fu, M., Exeter, D. J. & Anderson, A. The politics of relative deprivation: A transdisciplinary social justice perspective. Soc. Sci. Med. 133, 223–232 (2015).
    OpenUrl
  57. 57.↵
    Noppert, G. A. & Zalla, L. C. Who counts and who gets counted? health equity in infectious disease surveillance. Am. J. Public Health 111, 1004–1006 (2021).
    OpenUrl
  58. 58.↵
    Bugiardini, R. & Cenko, E. Sex differences in myocardial infarction deaths. Lancet 396, 72–73 (2020).
    OpenUrl
  59. 59.↵
    Siegel, R. L., Miller, K. D. & Jemal, A. Cancer Statistics, 2017. CA Cancer J. Clin. 67, 7–30 (2017).
    OpenUrlCrossRefPubMed
  60. 60.↵
    Miranda-Mendizabal, A. et al. Gender differences in suicidal behavior in adolescents and young adults: systematic review and meta-analysis of longitudinal studies. Int. J. Public Health 64, 265–283 (2019).
    OpenUrlPubMed
  61. 61.↵
    Okoro, C. A., Hollis, N. D., Cyrus, A. C. & Griffin-Blake, S. Prevalence of disabilities and health care access by disability status and type among adults - United States, 2016. MMWR Morb Mortal Wkly Rep 67, 882–887 (2018).
    OpenUrlPubMed
  62. 62.↵
    Sage, R., Ward, B., Myers, A. & Ravesloot, C. Transitory and enduring disability among urban and rural people. J. Rural Health 35, 460–470 (2019).
    OpenUrl
  63. 63.↵
    Jackson, C. L., Agénor, M., Johnson, D. A., Austin, S. B. & Kawachi, I. Sexual orientation identity disparities in health behaviors, outcomes, and services use among men and women in the United States: a cross-sectional study. BMC Public Health 16, 807 (2016).
    OpenUrl
Back to top
PreviousNext
Posted July 18, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Race, class, and place modify mortality rates for the top 12 causes of death, 1999-2021
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Race, class, and place modify mortality rates for the top 12 causes of death, 1999-2021
Allison Formanack, Ayush Doshi, Rupa Valdez, Ishan Williams, J Randall Moorman, Pavel Chernyavskiy
medRxiv 2022.06.14.22276404; doi: https://doi.org/10.1101/2022.06.14.22276404
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Race, class, and place modify mortality rates for the top 12 causes of death, 1999-2021
Allison Formanack, Ayush Doshi, Rupa Valdez, Ishan Williams, J Randall Moorman, Pavel Chernyavskiy
medRxiv 2022.06.14.22276404; doi: https://doi.org/10.1101/2022.06.14.22276404

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)